The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB–mediated mechanism
Open accessAbstract
Significance: Loss of skeletal muscle mass, or sarcopenia, is nearly universal in cirrhosis and adversely affects the outcome of these patients. There are no established therapies to prevent or reverse sarcopenia because the mechanisms are not known. We show that the expression of myostatin, a negative regulator of skeletal muscle mass, is increased in the cirrhotic muscle and is mediated by increased ammonia concentration. Skeletal muscle ammonia concentrations are significantly increased in cirrhosis, resulting in activation of the transcription factor NF-κB, which in turn increases the expression of myostatin. Given the high prevalence of cirrhosis, these studies are of broad general interest because ammonia-lowering strategies, NF-κB antagonists, and myostatin blocker are potential therapies to reverse sarcopenia of cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014 · cited 1×
“Even though the mechanisms of regulation of skeletal muscle mass by myostatin has been extensively studied (14, 34), there is very limited data on the upstream modulators of myostatin (35, 36).”
BackgroundMuscle Wasting Is Associated With Mortality in Patients With Cirrhosis
Montano–Loza, A. J., Meza–Junco, J., Prado, C. M. M., Lieffers, J. R., Baracos, V. E., Bain, V. G., & Sawyer, M. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.028 · Cited by 810
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784 · cited 1×
“Other effects of myostatin include inhibition of satellite cells (12) as well as increased proteolysis mediated by Akt inhibition (8, 9, 13, 14).”
BackgroundMcFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 480
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & Gonzalez-Cadavid, N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia.
Lockwood, A. H., McDonald, J. M., Reiman, R. E., Gelbard, A. S., Laughlin, J. S., Duffy, T. E., & Plum, F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109322 · Cited by 405
The role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 348
Amirouche, A., Durieux, A.-C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2009) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 282
Periyalwar, P., & Dasarathy, S. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.12.009 · Cited by 249
Self-citationBaeza-Raja, B., & Muñoz-Cánoves, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0585 · Cited by 247
Myostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
Benny Klimek, M. E., Aydogdu, T., Link, M. J., Pons, M., Koniaris, L. G., & Zimmers, T. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.123 · Cited by 229
Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis
Qiu, J., Tsien, C., Thapalaya, S., Narayanan, A., Weihl, C. C., Ching, J. K., Eghtesad, B., Singh, K., Fu, X., Dubyak, G., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00183.2012 · Cited by 214
Self-citationMa, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., & Bhasin, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1128 · Cited by 208
Bakkar, N., Wang, J., Ladner, K. J., Wang, H., Dahlman, J. M., Carathers, M., Acharyya, S., Rudnicki, M. A., Hollenbach, A. D., & Guttridge, D. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200707179 · Cited by 208
Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation
Huang, Z., Chen, X., & Chen, D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.003 · Cited by 176
Bakkar, N., Wang, J., Ladner, K. J., Wang, H., Dahlman, J. M., Carathers, M., Acharyya, S., Rudnicki, M. A., Hollenbach, A. D., & Guttridge, D. C. (2013) · Journal of Cell Biology · doi:10.1083/jcb.20070717908082013c · Cited by 174
The Myostatin Gene Is a Downstream Target Gene of Basic Helix-Loop-Helix Transcription Factor MyoD
Spiller, M. P., Kambadur, R., Jeanplong, F., Thomas, M., Martyn, J. K., Bass, J. J., & Sharma, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7066-7082.2002 · Cited by 166
Muscle nitrogen metabolism in chronic hepatic insufficiency
Ganda, O. P., & Ruderman, N. B. (1976) · Metabolism · doi:10.1016/0026-0495(76)90075-5 · Cited by 134
Welle, S. L., Burgess, K., & Mehta, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90862.2008 · Cited by 131
Self-citationSerum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease
Ju, C., & Chen, R. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.016 · Cited by 127
NFκB in the mechanism of ammonia‐induced astrocyte swelling in culture
Sinke, A. P., Jayakumar, A. R., Panickar, K. S., Moriyama, M., Reddy, P. V. B., & Norenberg, M. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05549.x · Cited by 121
Amino acids as regulators of gene expression: molecular mechanisms
Jousse, C., Avérous, J., Bruhat, A., Carraro, V., Mordier, S. B., & Fafournoux, P. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.07.020 · Cited by 118
Sarcopenia associated with portosystemic shunting is reversed by follistatin
Dasarathy, S., McCullough, A. J., Muc, S., Schneyer, A. L., Bennett, C. D., Dodig, M., & Kalhan, S. C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.032 · Cited by 113
Self-citationInterorgan ammonia trafficking in liver disease
Damink, S. W. M. O., Jalan, R., & Dejong, C. H. C. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9122-5 · Cited by 112
Dasarathy, S., Dodig, M., Muc, S., Kalhan, S. C., & McCullough, A. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00202.2004 · Cited by 110
Self-citationElevated Myostatin Levels in Patients with Liver Disease
García, P. S., Cabbabe, A., Kambadur, R., Nicholas, G., & CSETE, M. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181eac1c9 · Cited by 107
Increased Plasma Myostatin in Heart Failure
Gruson, D., Ahn, S. A., Ketelslegers, J., & Rousseau, M. F. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr024 · Cited by 106
Cytokines and glucocorticoids in the regulation of the “hepato-skeletal muscle axis” in sepsis
Fischer, J. E., & Hasselgren, P.-O. (1991) · The American Journal of Surgery · doi:10.1016/0002-9610(91)91143-7 · Cited by 69
Altered expression of genes regulating skeletal muscle mass in the portacaval anastamosis rat
Dasarathy, S., Muc, S., Hisamuddin, K., Edmison, J. M., Dodig, M., McCullough, A. J., & Kalhan, S. C. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00529.2006 · Cited by 61
Self-citationChatauret, N., Desjardins, P., Zwingmann, C., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.048 · Cited by 56
Shangraw, R. E., & Jahoor, F. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1145 · Cited by 54
Balasubramanian, S., Mani, S. K., Shiraishi, H., Johnston, R. K., Yamane, K., Willey, C. D., Cooper, G., Tuxworth, W. J., & Kuppuswamy, D. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.04.022 · Cited by 50
Effect of hyperammonemia on leucine and protein metabolism in rats
Holeček, M., Šprongl, L., & Tichý, M. (2000) · Metabolism · doi:10.1053/meta.2000.9531 · Cited by 47
Santis, C. D., & Jerry, D. R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.01.011 · Cited by 47
Muscle atrophy is not always sarcopenia
Hepple, R. T. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00304.2012 · Cited by 38
ter Schure, E. G., Silljé, H. H. W., Vermeulen, E. E., Kalhorn, J.-W., Verkleij, A. J., Boonstra, J., & Verrips, C. T. (1998) · Microbiology · doi:10.1099/00221287-144-5-1451 · Cited by 36
Cited by
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130
Self-citationNishikawa, H., Shiraki, M., Hiramatsu, A., Moriya, K., Hino, K., & Nishiguchi, S. (2016) · Hepatology Research · doi:10.1111/hepr.12774 · Cited by 656
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Self-citationSarcopenia and frailty in decompensated cirrhosis
Tandon, P., Montano-Loza, A. J., Lai, J. C., Dasarathy, S., & Merli, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.025 · Cited by 408
Self-citationSinclair, M., Gow, P. J., Grossmann, M., & Angus, P. W. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13549 · Cited by 316
Metadata
- Authors
- Qiu, J., Thapaliya, S., Runkana, A., Yang, Y., Tsien, C., Mohan, M. L., Narayanan, A., Eghtesad, B., Mozdziak, P. E., McDonald, C., Stark, G. R., Welle, S., Naga Prasad, S. V., & Dasarathy, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-10-21
- Volume
- 110
- Issue
- 45
- Pages
- 18162-18167
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2127764242
- Cited by
- 292
- References
- 38
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.